Literature DB >> 23333852

The Usp8 deubiquitination enzyme is post-translationally modified by tyrosine and serine phosphorylation.

Inez M J Meijer1, JoAnn Kerperien, Ana M Sotoca, Everardus J J van Zoelen, Jeroen E M van Leeuwen.   

Abstract

The ERBB1-ERBB4 receptors belong to a family of receptor tyrosine kinases that trigger a network of signaling pathways after ligand binding, thereby regulating cellular growth, differentiation and development. Ligand-induced signaling through ERBB1, also known as EGFR, is attenuated by the clathrin-dependent receptor-mediated endocytosis and RING E3-ligase Cbl-mediated receptor ubiquitination, which is followed by incorporation into multi-vesicular bodies (MVBs) and subsequent degradation in lysosomes. Before incorporation into MVBs, the EGFR is deubiquitinated by Usp8. We previously demonstrated that Usp8 is tyrosine phosphorylated in an EGFR- and SRC-kinase dependent manner. In the present study we show that overexpression of constitutively active SRC enhances constitutive and ligand-induced Usp8 tyrosine phosphorylation. We also show that enhanced endosomal recycling of the EGFR induced by TGFα stimulation is associated with decreased Usp8 tyrosine phosphorylation. We therefore hypothesize that tyrosine phosphorylation of Usp8 could regulate the function of Usp8. To identify Usp8 tyrosine phosphorylation site(s), we used Usp8 deletion constructs, site-directed mutagenesis of nine individual Usp8 tyrosine residues and mass spectrometry (MS) analysis. Our results demonstrate that the MIT-domain is necessary for ligand-induced tyrosine phosphorylation of Usp8 1-504. However, mutation of three MIT domain tyrosine residues did not abolish Usp8 tyrosine phosphorylation. Similar results were obtained upon mutation of six exposed tyrosine residues in the Rhod domain and linker region. Repeated MS analysis of both Usp8 WT and C748A mutants readily detected serine phosphorylation, including the S680 14-3-3 binding site, but did not reveal any phospho-tyrosine residues. Notably, mutation of the tyrosine residue in the Usp8 14-3-3 binding motif (Y679) did not abolish phosphoserine-dependent binding of 14-3-3 to Usp8. Our findings are most consistent with the model that MIT domain-dependent recruitment of Usp8 to endosomal membranes is important for low stoichiometry SRC-mediated tyrosine phosphorylation of multiple Usp8 tyrosines. Our findings demonstrate that Usp8 is a target for the post-translational serine and tyrosine phosphorylation, most likely characterized by low abundant tyrosine phosphorylation on multiple residues, and high abundant serine phosphorylation on several residues.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333852     DOI: 10.1016/j.cellsig.2013.01.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.

Authors:  Yunjung Kim; Aya Shiba-Ishii; Tomoki Nakagawa; Shun-Ichiro Iemura; Tohru Natsume; Noriyuki Nakano; Ryota Matsuoka; Shingo Sakashita; SangJoon Lee; Atsushi Kawaguchi; Yukio Sato; Masayuki Noguchi
Journal:  Oncogene       Date:  2018-06-07       Impact factor: 9.867

2.  Synaptic strength is bidirectionally controlled by opposing activity-dependent regulation of Nedd4-1 and USP8.

Authors:  Samantha L Scudder; Marisa S Goo; Anna E Cartier; Alice Molteni; Lindsay A Schwarz; Rebecca Wright; Gentry N Patrick
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

3.  USP8 Deubiquitinates the Leptin Receptor and Is Necessary for Leptin-Mediated Synapse Formation.

Authors:  Tyler Bland; Gulcan Semra Sahin; Mingyan Zhu; Crystal Dillon; Soren Impey; Suzanne M Appleyard; Gary A Wayman
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

Review 4.  USP8: a novel therapeutic target for Cushing's disease.

Authors:  Fangfang Jian; Yanan Cao; Liuguan Bian; Qingfang Sun
Journal:  Endocrine       Date:  2015-07-11       Impact factor: 3.633

Review 5.  When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling.

Authors:  Lan K Nguyen; Walter Kolch; Boris N Kholodenko
Journal:  Cell Commun Signal       Date:  2013-07-31       Impact factor: 5.712

6.  Somatic USP8 Gene Mutations Are a Common Cause of Pediatric Cushing Disease.

Authors:  Fabio R Faucz; Amit Tirosh; Christina Tatsi; Annabel Berthon; Laura C Hernández-Ramírez; Nikolaos Settas; Anna Angelousi; Ricardo Correa; Georgios Z Papadakis; Prashant Chittiboina; Martha Quezado; Nathan Pankratz; John Lane; Aggeliki Dimopoulos; James L Mills; Maya Lodish; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

Review 7.  Deubiquitinases in Neurodegeneration.

Authors:  Abudu I Bello; Rituparna Goswami; Shelby L Brown; Kara Costanzo; Taylor Shores; Shefaa Allan; Revan Odah; Ryan D Mohan
Journal:  Cells       Date:  2022-02-05       Impact factor: 6.600

Review 8.  Regulation of Deubiquitinating Enzymes by Post-Translational Modifications.

Authors:  Tanuza Das; Sang Chul Shin; Eun Joo Song; Eunice EunKyeong Kim
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.